Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 176 entries
Sorted by: Best Match Show Resources per page
ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches.

Pharmacogenomics and personalized medicine

Cleophas MC, Joosten LA, Stamp LK, Dalbeth N, Woodward OM, Merriman TR.
PMID: 28461764
Pharmgenomics Pers Med. 2017 Apr 20;10:129-142. doi: 10.2147/PGPM.S105854. eCollection 2017.

As a result of the association of a common polymorphism (

Cite
Cleophas MC, Joosten LA, Stamp LK, et al. ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches. Pharmgenomics Pers Med. 2017;10:129-142doi: 10.2147/PGPM.S105854.
Cleophas, M. C., Joosten, L. A., Stamp, L. K., Dalbeth, N., Woodward, O. M., & Merriman, T. R. (2017). ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches. Pharmacogenomics and personalized medicine, 10129-142. https://doi.org/10.2147/PGPM.S105854
Cleophas, M C, et al. "ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches." Pharmacogenomics and personalized medicine vol. 10 (2017): 129-142. doi: https://doi.org/10.2147/PGPM.S105854
Cleophas MC, Joosten LA, Stamp LK, Dalbeth N, Woodward OM, Merriman TR. ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches. Pharmgenomics Pers Med. 2017 Apr 20;10:129-142. doi: 10.2147/PGPM.S105854. eCollection 2017. PMID: 28461764; PMCID: PMC5404803.
Copy Download .nbib Format: NLM
Gene polymorphisms in pattern recognition receptors and susceptibility to idiopathic recurrent vulvovaginal candidiasis.

Frontiers in microbiology

Rosentul DC, Delsing CE, Jaeger M, Plantinga TS, Oosting M, Costantini I, Venselaar H, Joosten LA, van der Meer JW, Dupont B, Kullberg BJ, Sobel JD, Netea MG.
PMID: 25295030
Front Microbiol. 2014 Sep 23;5:483. doi: 10.3389/fmicb.2014.00483. eCollection 2014.

OBJECTIVE: Approximately 5% of women suffer from recurrent vulvovaginal candidiasis (RVVC). It has been hypothesized that genetic factors play an important role in the susceptibility to RVVC. The aim of this study was to assess the effect of genetic...

Cite
Rosentul DC, Delsing CE, Jaeger M, et al. Gene polymorphisms in pattern recognition receptors and susceptibility to idiopathic recurrent vulvovaginal candidiasis. Front Microbiol. 2014;5:483doi: 10.3389/fmicb.2014.00483.
Rosentul, D. C., Delsing, C. E., Jaeger, M., Plantinga, T. S., Oosting, M., Costantini, I., Venselaar, H., Joosten, L. A., van der Meer, J. W., Dupont, B., Kullberg, B. J., Sobel, J. D., & Netea, M. G. (2014). Gene polymorphisms in pattern recognition receptors and susceptibility to idiopathic recurrent vulvovaginal candidiasis. Frontiers in microbiology, 5483. https://doi.org/10.3389/fmicb.2014.00483
Rosentul, Diana C, et al. "Gene polymorphisms in pattern recognition receptors and susceptibility to idiopathic recurrent vulvovaginal candidiasis." Frontiers in microbiology vol. 5 (2014): 483. doi: https://doi.org/10.3389/fmicb.2014.00483
Rosentul DC, Delsing CE, Jaeger M, Plantinga TS, Oosting M, Costantini I, Venselaar H, Joosten LA, van der Meer JW, Dupont B, Kullberg BJ, Sobel JD, Netea MG. Gene polymorphisms in pattern recognition receptors and susceptibility to idiopathic recurrent vulvovaginal candidiasis. Front Microbiol. 2014 Sep 23;5:483. doi: 10.3389/fmicb.2014.00483. eCollection 2014. PMID: 25295030; PMCID: PMC4172055.
Copy Download .nbib Format: NLM
Defensive properties of pyrrolizidine alkaloids against microorganisms.

Phytochemistry reviews : proceedings of the Phytochemical Society of Europe

Joosten L, van Veen JA.
PMID: 21475390
Phytochem Rev. 2011 Mar;10(1):127-136. doi: 10.1007/s11101-010-9204-y. Epub 2010 Nov 23.

The understanding of the selection factors that drive chemical diversification of secondary metabolites of constitutive defence systems in plants, such as pyrrolizidine alkaloids (PAs), is still incomplete. Historically, plants always have been confronted with microorganisms. Long before herbivores existed...

Cite
Joosten L, van Veen JA. Defensive properties of pyrrolizidine alkaloids against microorganisms. Phytochem Rev. 2010;10(1):127-136doi: 10.1007/s11101-010-9204-y.
Joosten, L., & van Veen, J. A. (2011). Defensive properties of pyrrolizidine alkaloids against microorganisms. Phytochemistry reviews : proceedings of the Phytochemical Society of Europe, 10(1), 127-136. https://doi.org/10.1007/s11101-010-9204-y
Joosten, Lotte, and van Veen, Johannes A. "Defensive properties of pyrrolizidine alkaloids against microorganisms." Phytochemistry reviews : proceedings of the Phytochemical Society of Europe vol. 10,1 (2011): 127-136. doi: https://doi.org/10.1007/s11101-010-9204-y
Joosten L, van Veen JA. Defensive properties of pyrrolizidine alkaloids against microorganisms. Phytochem Rev. 2011 Mar;10(1):127-136. doi: 10.1007/s11101-010-9204-y. Epub 2010 Nov 23. PMID: 21475390; PMCID: PMC3047671.
Copy Download .nbib Format: NLM
Copper(I)-assembled [3]rotaxane whose two rings act as flapping wings.

Journal of the American Chemical Society

Joosten A, Trolez Y, Collin JP, Heitz V, Sauvage JP.
PMID: 22236438
J Am Chem Soc. 2012 Jan 25;134(3):1802-9. doi: 10.1021/ja210113y. Epub 2012 Jan 10.

A new copper-complexed [3]rotaxane consisting of two coordinating 30-membered rings threaded by a two-binding-site axis has been prepared in good yield from relatively simple organic fragments. The main specificity of the system originates from the stoppering reaction, based on...

Cite
Joosten A, Trolez Y, Collin JP, et al. Copper(I)-assembled [3]rotaxane whose two rings act as flapping wings. J Am Chem Soc. 2012;134(3):1802-9doi: 10.1021/ja210113y.
Joosten, A., Trolez, Y., Collin, J. P., Heitz, V., & Sauvage, J. P. (2012). Copper(I)-assembled [3]rotaxane whose two rings act as flapping wings. Journal of the American Chemical Society, 134(3), 1802-9. https://doi.org/10.1021/ja210113y
Joosten, Antoine, et al. "Copper(I)-assembled [3]rotaxane whose two rings act as flapping wings." Journal of the American Chemical Society vol. 134,3 (2012): 1802-9. doi: https://doi.org/10.1021/ja210113y
Joosten A, Trolez Y, Collin JP, Heitz V, Sauvage JP. Copper(I)-assembled [3]rotaxane whose two rings act as flapping wings. J Am Chem Soc. 2012 Jan 25;134(3):1802-9. doi: 10.1021/ja210113y. Epub 2012 Jan 10. PMID: 22236438.
Copy Download .nbib Format: NLM
Giant Glycosidase Inhibitors: First- and Second-Generation Fullerodendrimers with a Dense Iminosugar Shell.

Chemistry (Weinheim an der Bergstrasse, Germany)

Nierengarten JF, Schneider JP, Trinh TMN, Joosten A, Holler M, Lepage ML, Bodlenner A, García-Moreno MI, Ortiz Mellet C, Compain P.
PMID: 29281149
Chemistry. 2018 Feb 16;24(10):2483-2492. doi: 10.1002/chem.201705600. Epub 2018 Jan 25.

The multivalent effect in glycosidase inhibition is a new topic in glycoscience that has emerged a few years ago, with the discovery of neoglycoclusters displaying strong binding enhancements over the corresponding monovalent inhibitor. Iminosugar-fullerene conjugates with high valencies have...

Cite
Nierengarten JF, Schneider JP, Trinh TMN, et al. Giant Glycosidase Inhibitors: First- and Second-Generation Fullerodendrimers with a Dense Iminosugar Shell. Chemistry. 2018;24(10):2483-2492doi: 10.1002/chem.201705600.
Nierengarten, J. F., Schneider, J. P., Trinh, T. M. N., Joosten, A., Holler, M., Lepage, M. L., Bodlenner, A., García-Moreno, M. I., Ortiz Mellet, C., & Compain, P. (2018). Giant Glycosidase Inhibitors: First- and Second-Generation Fullerodendrimers with a Dense Iminosugar Shell. Chemistry (Weinheim an der Bergstrasse, Germany), 24(10), 2483-2492. https://doi.org/10.1002/chem.201705600
Nierengarten, Jean-François, et al. "Giant Glycosidase Inhibitors: First- and Second-Generation Fullerodendrimers with a Dense Iminosugar Shell." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 24,10 (2018): 2483-2492. doi: https://doi.org/10.1002/chem.201705600
Nierengarten JF, Schneider JP, Trinh TMN, Joosten A, Holler M, Lepage ML, Bodlenner A, García-Moreno MI, Ortiz Mellet C, Compain P. Giant Glycosidase Inhibitors: First- and Second-Generation Fullerodendrimers with a Dense Iminosugar Shell. Chemistry. 2018 Feb 16;24(10):2483-2492. doi: 10.1002/chem.201705600. Epub 2018 Jan 25. PMID: 29281149.
Copy Download .nbib Format: NLM
A Randomized Controlled Trial of a Play-Based, Peer-Mediated Pragmatic Language Intervention for Children With Autism.

Frontiers in psychology

Parsons L, Cordier R, Munro N, Joosten A.
PMID: 31611828
Front Psychol. 2019 Aug 27;10:1960. doi: 10.3389/fpsyg.2019.01960. eCollection 2019.

PURPOSE: This randomized controlled trial evaluated the effectiveness of a play-based pragmatic language intervention for children with autism.METHODS: A sample of 71 children with autism were randomized to an intervention-first group (RESULTS: POM-2 gains were greatest for intervention-first participants...

Cite
Parsons L, Cordier R, Munro N, et al. A Randomized Controlled Trial of a Play-Based, Peer-Mediated Pragmatic Language Intervention for Children With Autism. Front Psychol. 2019;10:1960doi: 10.3389/fpsyg.2019.01960.
Parsons, L., Cordier, R., Munro, N., & Joosten, A. (2019). A Randomized Controlled Trial of a Play-Based, Peer-Mediated Pragmatic Language Intervention for Children With Autism. Frontiers in psychology, 101960. https://doi.org/10.3389/fpsyg.2019.01960
Parsons, Lauren, et al. "A Randomized Controlled Trial of a Play-Based, Peer-Mediated Pragmatic Language Intervention for Children With Autism." Frontiers in psychology vol. 10 (2019): 1960. doi: https://doi.org/10.3389/fpsyg.2019.01960
Parsons L, Cordier R, Munro N, Joosten A. A Randomized Controlled Trial of a Play-Based, Peer-Mediated Pragmatic Language Intervention for Children With Autism. Front Psychol. 2019 Aug 27;10:1960. doi: 10.3389/fpsyg.2019.01960. eCollection 2019. PMID: 31611828; PMCID: PMC6776827.
Copy Download .nbib Format: NLM
Transition from early intervention program to primary school in children with autism spectrum disorder.

World journal of clinical pediatrics

Eapen V, Grove R, Aylward E, Joosten AV, Miller SI, Van Der Watt G, Fordyce K, Dissanayake C, Maya J, Tucker M, DeBlasio A.
PMID: 29259892
World J Clin Pediatr. 2017 Nov 08;6(4):169-175. doi: 10.5409/wjcp.v6.i4.169. eCollection 2017 Nov 08.

AIM: To evaluate the characteristics that are associated with successful transition to school outcomes in preschool aged children with autism.METHODS: Twenty-one participants transitioning from an early intervention program were assessed at two time points; at the end of their...

Cite
Eapen V, Grove R, Aylward E, et al. Transition from early intervention program to primary school in children with autism spectrum disorder. World J Clin Pediatr. 2017;6(4):169-175doi: 10.5409/wjcp.v6.i4.169.
Eapen, V., Grove, R., Aylward, E., Joosten, A. V., Miller, S. I., Van Der Watt, G., Fordyce, K., Dissanayake, C., Maya, J., Tucker, M., & DeBlasio, A. (2017). Transition from early intervention program to primary school in children with autism spectrum disorder. World journal of clinical pediatrics, 6(4), 169-175. https://doi.org/10.5409/wjcp.v6.i4.169
Eapen, Valsamma, et al. "Transition from early intervention program to primary school in children with autism spectrum disorder." World journal of clinical pediatrics vol. 6,4 (2017): 169-175. doi: https://doi.org/10.5409/wjcp.v6.i4.169
Eapen V, Grove R, Aylward E, Joosten AV, Miller SI, Van Der Watt G, Fordyce K, Dissanayake C, Maya J, Tucker M, DeBlasio A. Transition from early intervention program to primary school in children with autism spectrum disorder. World J Clin Pediatr. 2017 Nov 08;6(4):169-175. doi: 10.5409/wjcp.v6.i4.169. eCollection 2017 Nov 08. PMID: 29259892; PMCID: PMC5695075.
Copy Download .nbib Format: NLM
Procedure-Specific Pain Intensity Four Days After Day Surgery and the Relationship with Preoperative Pain: A Prospective Cohort Study.

Anesthesiology and pain medicine

Vrancken D, Theunissen M, Joosten EA, Fiddelers AAA, Hoofwijk DMN, Buhre WFFA, Gramke HF, Stessel BOR.
PMID: 30719413
Anesth Pain Med. 2018 Nov 17;8(6):e81366. doi: 10.5812/aapm.81366. eCollection 2018 Dec.

BACKGROUND: Identification of painful procedures is essential for the development of procedure-specific pain-treatment schedules. The aim of this study was firstly, to analyze the prevalence of acute postsurgical pain (APSP) after various types of day surgery on the fourth...

Cite
Vrancken D, Theunissen M, Joosten EA, et al. Procedure-Specific Pain Intensity Four Days After Day Surgery and the Relationship with Preoperative Pain: A Prospective Cohort Study. Anesth Pain Med. 2018;8(6):e81366doi: 10.5812/aapm.81366.
Vrancken, D., Theunissen, M., Joosten, E. A., Fiddelers, A. A. A., Hoofwijk, D. M. N., Buhre, W. F. F. A., Gramke, H. F., & Stessel, B. O. R. (2018). Procedure-Specific Pain Intensity Four Days After Day Surgery and the Relationship with Preoperative Pain: A Prospective Cohort Study. Anesthesiology and pain medicine, 8(6), e81366. https://doi.org/10.5812/aapm.81366
Vrancken, Dirk, et al. "Procedure-Specific Pain Intensity Four Days After Day Surgery and the Relationship with Preoperative Pain: A Prospective Cohort Study." Anesthesiology and pain medicine vol. 8,6 (2018): e81366. doi: https://doi.org/10.5812/aapm.81366
Vrancken D, Theunissen M, Joosten EA, Fiddelers AAA, Hoofwijk DMN, Buhre WFFA, Gramke HF, Stessel BOR. Procedure-Specific Pain Intensity Four Days After Day Surgery and the Relationship with Preoperative Pain: A Prospective Cohort Study. Anesth Pain Med. 2018 Nov 17;8(6):e81366. doi: 10.5812/aapm.81366. eCollection 2018 Dec. PMID: 30719413; PMCID: PMC6347732.
Copy Download .nbib Format: NLM
100 years of the Bacillus Calmette-Guérin vaccine.

Vaccine

Bettencourt PJG, Joosten SA, Lindestam Arlehamn CS, Behr MA, Locht C, Neyrolles O.
PMID: 34823911
Vaccine. 2021 Dec 08;39(50):7221-7222. doi: 10.1016/j.vaccine.2021.11.038. Epub 2021 Nov 22.

No abstract available.

Cite
Bettencourt PJG, Joosten SA, Lindestam Arlehamn CS, et al. 100 years of the Bacillus Calmette-Guérin vaccine. Vaccine. 2021;39(50):7221-7222doi: 10.1016/j.vaccine.2021.11.038.
Bettencourt, P. J. G., Joosten, S. A., Lindestam Arlehamn, C. S., Behr, M. A., Locht, C., & Neyrolles, O. (2021). 100 years of the Bacillus Calmette-Guérin vaccine. Vaccine, 39(50), 7221-7222. https://doi.org/10.1016/j.vaccine.2021.11.038
Bettencourt, Paulo J G, et al. "100 years of the Bacillus Calmette-Guérin vaccine." Vaccine vol. 39,50 (2021): 7221-7222. doi: https://doi.org/10.1016/j.vaccine.2021.11.038
Bettencourt PJG, Joosten SA, Lindestam Arlehamn CS, Behr MA, Locht C, Neyrolles O. 100 years of the Bacillus Calmette-Guérin vaccine. Vaccine. 2021 Dec 08;39(50):7221-7222. doi: 10.1016/j.vaccine.2021.11.038. Epub 2021 Nov 22. PMID: 34823911; PMCID: PMC8638750.
Copy Download .nbib Format: NLM
Early-life exposure to selective serotonin reuptake inhibitors: long-term effects on pain and affective comorbidities.

The European journal of neuroscience

Baudat M, de Kort AR, van den Hove DLA, Joosten EAJ.
PMID: 34841582
Eur J Neurosci. 2021 Nov 29; doi: 10.1111/ejn.15544. Epub 2021 Nov 29.

A growing body of evidence indicate that early-life exposure to selective serotonin reuptake inhibitor has long-term consequences on the offspring's pain in addition to affective disorders like anxiety disorder and major depression. Serotonin, beside its role in regulating pain...

Cite
Baudat M, de Kort AR, van den Hove DLA, et al. Early-life exposure to selective serotonin reuptake inhibitors: long-term effects on pain and affective comorbidities. Eur J Neurosci. 2021;doi: 10.1111/ejn.15544.
Baudat, M., de Kort, A. R., van den Hove, D. L. A., & Joosten, E. A. J. (2021). Early-life exposure to selective serotonin reuptake inhibitors: long-term effects on pain and affective comorbidities. The European journal of neuroscience, . https://doi.org/10.1111/ejn.15544
Baudat, Mathilde, et al. "Early-life exposure to selective serotonin reuptake inhibitors: long-term effects on pain and affective comorbidities." The European journal of neuroscience vol. (2021). doi: https://doi.org/10.1111/ejn.15544
Baudat M, de Kort AR, van den Hove DLA, Joosten EAJ. Early-life exposure to selective serotonin reuptake inhibitors: long-term effects on pain and affective comorbidities. Eur J Neurosci. 2021 Nov 29; doi: 10.1111/ejn.15544. Epub 2021 Nov 29. PMID: 34841582.
Copy Download .nbib Format: NLM
Protective immune response mediated by neutrophils in experimental visceral leishmaniasis is enhanced by IL-32γ.

Cellular immunology

Gomes RS, Silva MVT, Oliveira MAP, Joosten LAB, Ribeiro-Dias F.
PMID: 34784560
Cell Immunol. 2021 Nov 10;371:104449. doi: 10.1016/j.cellimm.2021.104449. Epub 2021 Nov 10.

Neutrophils are important cells in protection against microbial infections including visceral leishmaniasis (VL). It is well known that IL-32γ increases the protective T helper 17 cell mediated immune response against Leishmania infantum. Thus, in this study we evaluated whether...

Cite
Gomes RS, Silva MVT, Oliveira MAP, et al. Protective immune response mediated by neutrophils in experimental visceral leishmaniasis is enhanced by IL-32γ. Cell Immunol. 2021;371:104449doi: 10.1016/j.cellimm.2021.104449.
Gomes, R. S., Silva, M. V. T., Oliveira, M. A. P., Joosten, L. A. B., & Ribeiro-Dias, F. (2021). Protective immune response mediated by neutrophils in experimental visceral leishmaniasis is enhanced by IL-32γ. Cellular immunology, 371104449. https://doi.org/10.1016/j.cellimm.2021.104449
Gomes, Rodrigo Saar, et al. "Protective immune response mediated by neutrophils in experimental visceral leishmaniasis is enhanced by IL-32γ." Cellular immunology vol. 371 (2021): 104449. doi: https://doi.org/10.1016/j.cellimm.2021.104449
Gomes RS, Silva MVT, Oliveira MAP, Joosten LAB, Ribeiro-Dias F. Protective immune response mediated by neutrophils in experimental visceral leishmaniasis is enhanced by IL-32γ. Cell Immunol. 2021 Nov 10;371:104449. doi: 10.1016/j.cellimm.2021.104449. Epub 2021 Nov 10. PMID: 34784560.
Copy Download .nbib Format: NLM
Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease.

Blood

Molteni R, Biavasco R, Stefanoni D, Nemkov T, Domínguez-Andrés J, Arts RJ, Merelli I, Mazza D, Zambrano S, Panigada M, Cantoni E, Tengesdal IW, Maksud P, Piras F, Cesana D, Cassina L, Distefano G, Loffreda A, Gnani D, De Luca G, Tomelleri A, Campochiaro C, Joosten LAB, Dinarello CA, Kajaste-Rudnitski A, Haroche J, Cardaci S, Cenci S, Dagna L, Doglioni C, Ferrarini M, Ferrero E, Boletta A, D'Alessandro A, Montini E, Netea MG, Cavalli G.
PMID: 34077954
Blood. 2021 Oct 28;138(17):1554-1569. doi: 10.1182/blood.2020009594.

Trained immunity (TI) is a proinflammatory program induced in monocyte/macrophages upon sensing of specific pathogens and is characterized by immunometabolic and epigenetic changes that enhance cytokine production. Maladaptive activation of TI (ie, in the absence of infection) may result...

Cite
Molteni R, Biavasco R, Stefanoni D, et al. Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease. Blood. 2021;138(17):1554-1569doi: 10.1182/blood.2020009594.
Molteni, R., Biavasco, R., Stefanoni, D., Nemkov, T., Domínguez-Andrés, J., Arts, R. J., Merelli, I., Mazza, D., Zambrano, S., Panigada, M., Cantoni, E., Tengesdal, I. W., Maksud, P., Piras, F., Cesana, D., Cassina, L., Distefano, G., Loffreda, A., Gnani, D., De Luca, G., Tomelleri, A., Campochiaro, C., Joosten, L. A. B., Dinarello, C. A., Kajaste-Rudnitski, A., Haroche, J., Cardaci, S., Cenci, S., Dagna, L., Doglioni, C., Ferrarini, M., Ferrero, E., Boletta, A., D'Alessandro, A., Montini, E., Netea, M. G., & Cavalli, G. (2021). Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease. Blood, 138(17), 1554-1569. https://doi.org/10.1182/blood.2020009594
Molteni, Raffaella, et al. "Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease." Blood vol. 138,17 (2021): 1554-1569. doi: https://doi.org/10.1182/blood.2020009594
Molteni R, Biavasco R, Stefanoni D, Nemkov T, Domínguez-Andrés J, Arts RJ, Merelli I, Mazza D, Zambrano S, Panigada M, Cantoni E, Tengesdal IW, Maksud P, Piras F, Cesana D, Cassina L, Distefano G, Loffreda A, Gnani D, De Luca G, Tomelleri A, Campochiaro C, Joosten LAB, Dinarello CA, Kajaste-Rudnitski A, Haroche J, Cardaci S, Cenci S, Dagna L, Doglioni C, Ferrarini M, Ferrero E, Boletta A, D'Alessandro A, Montini E, Netea MG, Cavalli G. Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease. Blood. 2021 Oct 28;138(17):1554-1569. doi: 10.1182/blood.2020009594. PMID: 34077954.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 176 entries